Nutraplus India Ltd

Key Stats

₹1.9
Day's Price Range
₹2.1
₹1.82
52-Week Price Range
₹2.91

Company Financials

  • Quarterly
  • Annual
Value in ₹ crore

Peer Comparsion

PE
Rank 75
-0.11
EPS
Rank 72
₹-19.7
BVPS
Rank 65
₹17
Dividend Yield
Rank 41
ROE
Rank 120
Price To Book Ratio
0.12
Debt To Asset
Rank 21
0.58

Company Information

Nutraplus Products India Limited was originally incorporated as a private limited company on 6 Feb.90. It was subsequently converted into a public limited company with effect from 13 Jun.92. The company implemented a project for the manufacture of veterinary bulk drugs namely dimentridazole DMZ and dinitolmide DOT at Tarapur Maharashtra. Initially the company set up manufacturing facilities for the manufacture of methyl nitro imidazole an intermediate of DMZ with an installed capacity of 240 tpa at a cost of Rs 123.66 lac for which was sanctioned a term loan of Rs 60 lac from the Maharashtra State Financial Corporation MSFC.The company has setup new product Roxarsone from Jan96 and also set up production of Dinitolmide. During 200102 the company set up a production of newly developed Bulk Drugs Metformin HCL. It is also planning to foray in the manufacture of life saving drugs.
OrganisationNutraplus India Ltd
HeadquartersThane
IndustryPharmaceuticals